Home›Companies›Biotech & Pharma›Arthrosi Therapeutics

Arthrosi Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 24, 2025·Suggest an edit

About Arthrosi Therapeutics

Arthrosi Therapeutics is a private company based in Laguna Hills, California. It has reported $132,872,520 raised in eight offerings on Form D since June 2018. Its chief executive is Litain Yeh.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 6, 2025Jun 24, 2025$60,869,972of $153.1M target13$4.6MEquityRule 506(b)Form D ↗
Sep 5, 2023Jan 26, 2024$7,000,000of $75.0M target1$7.0MEquityRule 506(b)Form D ↗
Feb 7, 2023Mar 3, 2023$15,000,000of $20.0M target2$7.5MEquityRule 506(b)Form D ↗
Aug 16, 2021Nov 15, 2021$26,000,000of $30.0M target2$13.0MEquityRule 506(b)Form D ↗
Aug 2, 2021Nov 15, 2021$220,000fully sold1$220KEquityRule 506(b)Form D ↗
May 20, 2020Jun 3, 2020$8,500,000of $20.0M target3$2.8MEquityRule 506(b)Form D ↗
Oct 29, 2018Jan 30, 2019$11,000,000fully sold3$3.6MEquityRule 506(b)Form D ↗
Jan 24, 2018Jun 29, 2018$4,282,548fully sold3$1.4MEquityRule 506(b)Form D ↗
Total, eight offerings$132,872,520

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Arthrosi Therapeutics's Form D filed Jun 24, 2025.

ZM
CY
Chaohua Yuan
Director
XW
JL
John Leaman
Director
HL
Hanxiong Li
Director
TH
Thomas Huang
Director
XX
Xin Xie
Director
LY
Litain Yeh
CEO and director
SY
Shunqi Yan
Executive officer, director and promoter

Earlier filings also listed Xiaojia Cai (director, last listed Jan 2024), James McKay (director, last listed Jan 2024), Yiwei Zong (director, last listed Mar 2023), Yiwei Zhong (director, last listed Nov 2021), James Mackay (director, last listed Nov 2021), Cynthia Cai (director, last listed Nov 2021), Robert Orr (executive officer, director and promoter, last listed Jun 2020) and Jianhua Cai (director, last listed Jun 2020).

Sources

  1. SECArthrosi Therapeutics, Inc. filing history